ArticleApplied psychophysiology and biofeedback2026
Effects of Transcutaneous Vagus Nerve Stimulation, Neurofeedback, and their Combination on Cortisol, Anxiety, and Depression Subtypes in Non-Clinical Adults.
Article in Applied psychophysiology and biofeedback, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Transcutaneous auricular vagus nerve stimulation, tolerability, and the Alpha/Theta EEG ratio: a controlled pilot study relevant to emotion regulation.Frontiers in psychiatry · 2026Article
- Mechanistic insights into combined prefrontal tDCS and vagal nerve stimulation for stress regulation.Frontiers in psychology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Non-invasive neuromodulation techniques such as neurofeedback (NF) and transcutaneous vagus nerve stimulation (tVNS) are attracting growing interest for their potential to influence brain activity and emotional regulation. This pilot study investigated the individual and combined effects of these methods on psychological measures, electrophysiological markers, and salivary cortisol. Twenty healthy young adults (19 females, 1 male, aged 18–24) participated, with outcomes including psychological measures (anxiety and depression), EEG Alpha / Theta ratio, and salivary cortisol. NF was associated with significant reductions in anxiety and depressive symptoms. Notably, despite the NF protocol directly targeting Alpha / Theta oscillations, a significant increase in the Alpha / Theta ratio was observed only in the tVNS group, indicating a distinct bottom-up influence on neural dynamics. The combined intervention did not yield additional benefits, and cortisol levels remained unchanged. These preliminary findings suggest that NF and tVNS may operate through distinct pathways—NF influencing psychological outcomes via top-down regulation and tVNS modulating electrophysiological activity via bottom-up pathways. The absence of sham control conditions limits causal attribution of effects. Given the small sample size (n = 5 per group) and exploratory nature of this study, these results should be interpreted as hypothesis-generating and require replication in larger, adequately powered trials.
Indexed as
Identifiers
41493526What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.